A case of fulminant type 1 diabetes mellitus during steroid therapy for hypersensitivity syndrome

Journal of the Japan Diabetes Society

Volumn 44, Issue 11, 2001, Pages 907-912

  Ohta, K ^a   Takamoto, T ^a   Izumi, H ^a   Yoshida, T ^a   Ishihara, Y ^a   Hirata, Y ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; LIOTHYRONINE; MEXILETINE; PANCREAS ISLET CELL ANTIBODY; STEROID; THYROTROPIN; THYROXINE;

ADULT; ARTICLE; CASE REPORT; DIABETIC KETOACIDOSIS; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN HERPESVIRUS 6; HYPERSENSITIVITY; INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; STEROID THERAPY; VIRUS REACTIVATION;

EID: 0035671536     PISSN: 0021437X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies
2. A novel subtype of type 1 diabetes mellitus
3. Association of HLA-A 24 with complete β-cell destruction in IDDM
4. Severe adverse cutaneous reactions to drugs
5. Human herpesvirus 6 infection as a risk factor for the development of severe drug-induced hypersensitivity syndrome
6. Severe hypersensitive syndrome due to sulfasalazine associated with reactivation of human herpesvirus 6
7. Rapid loss of insulin secretion in a patient with fulminant type 1 diabetes and carbamazepine hypersensitivity syndrome
8. Immunity to Microbes
9. Drug-induced hypothyroidism: The thyroid as a target organ in hypersensitivity reactions to anticonvulsants and sulfonamides
10. Anticonvulsant hypersensitivity syndrome